Jessica Staley
Payments from drug & device makers
Across 121 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$606
- Bayer$310
- Lilly USA, LLC$144
- Novartis$139
- Dexcom, Inc.$119
- Amgen$116
- plus $899 from 27 others
What the payments were for
- Food & beverage$2,333100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 38 | $606 |
| Bayer | 8 | $310 |
| Lilly USA, LLC | 7 | $144 |
| Novartis | 8 | $139 |
| Dexcom, Inc. | 6 | $119 |
| Amgen | 6 | $116 |
| Radius Health, Inc. | 4 | $91 |
| Sanofi-aventis U.S. LLC | 4 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $66 |
| Corcept Therapeutics | 2 | $57 |
| Abbott | 3 | $42 |
| AstraZeneca(2 entities) | 2 | $42 |
| Antares Pharma, Inc. | 2 | $39 |
| Medtronic | 2 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| Amryt Pharma Holdings Ltd | 2 | $29 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Tandem Diabetes Care, Inc. | 2 | $28 |
| Ascensia Diabetes Care US Inc. | 2 | $27 |
| Sequel Med Tech, LLC | 1 | $25 |
| AbbVie | 1 | $25 |
| BETA Bionics, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Insulet Corporation | 1 | $14 |
| Cequr Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,333 in reported general payments places this provider in the 80th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 241 | $282,327 |
| JardianceEmpagliflozin | 159 | $151,127 |
| TrulicityDulaglutide | 64 | $88,131 |
| Tresiba Flextouch U-200Insulin Degludec | 58 | $81,708 |
| Teriparatide | 28 | $77,610 |
| Tresiba Flextouch U-100Insulin Degludec | 95 | $68,755 |
| MounjaroTirzepatide | 58 | $64,386 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 41 | $61,281 |
| FarxigaDapagliflozin Propanediol | 44 | $51,718 |
| Humalog Kwikpen U-100Insulin Lispro | 132 | $45,399 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $40,739 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 29 | $39,648 |
| JanuviaSitagliptin Phosphate | 23 | $26,636 |
| TradjentaLinagliptin | 35 | $22,915 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 125 | $22,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $606 | $300,929252 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $34 | $213,690223 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $144 | $152,517122 claims |
| AstraZenecaFarxiga | $42 | $51,71844 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $32 | $7,543858 claims |
| AbbVieSynthroid | $25 | $5,425125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 547 medical providers in Ohio.
Other medical in Akron
- Kodi VealeAkron$43K
- Lara YoungAkron$8K
- Brooke HolmgrenAkron$6K
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.